Tuesday, September 20, 2011 11:54:36 AM
http://ih.advfn.com/p.php?pid=nmona&article=49227858&symbol=PKI
Securities lawyers at Goldfarb Branham LLP are investigating whether board of directors of Caliper Life Sciences (NASDAQ: CALP) violated shareholder protection laws in its proposed buyout by PerkinElmer, Inc. (NASDAQ: PKI) for $10.50 per share. Concerned investors are encouraged to contact attorney Hamilton Lindley at 877-583-2855 or hlindley@goldfarbbranham.com about their rights and remedies.
"The offer represents a premium of 42% for CALP shareholders, but the company reported on September 7, 2011 that it has $34 million as a result of organic growth, which is up 24% for the first half of the year. The buyout will result in a cash out for shareholders while CEO Robert F. Friel remains with the company," securities lawyer Hamilton Lindley said. "Our proposed class action lawsuit seeks to ensure that the investors received reasonable value and information in this buyout."
Goldfarb Branham LLP lawyers have significant experience representing shareholders and whistleblowers in securities lawsuits nationwide. CALP investors – or anyone with knowledge about this acquisition – should contact lawyer Hamilton Lindley at hlindley@goldfarbbranham.com or 877-583-2855.
Hamilton Lindley Goldfarb Branham LLP2501 N. Harwood, Ste. 1801Dallas, TX 75201(877) 583-2855 Toll Free Telephone (214) 583-2233 Local Phone Number (214) 583-2234 Fax Number hlindley@goldfarbbranham.comwww.goldfarbbranham.com
SOURCE Goldfarb Branham LLP
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM